| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.093 | 0.06 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.057 | 0.2 |